At Novartis, we don’t just discover life-changing medicines, we're part of a broader effort to help ensure medicines reach the people who need them most, wherever they live, because the true value of innovation lies in its ability to improve lives.
Ensuring people everywhere can benefit from the latest medical breakthroughs is a shared global responsibility – one we care deeply about and work hard to uphold through our science, value and access initiatives, and government and community partnerships. Yet, this shared responsibility has grown out of balance, with a disproportionate burden placed on certain countries and even patients.
We believe developed countries should be investing in innovative medicines proportionate to their economy, to ensure access to the latest advances for their people today and to help fuel the continued development of the next wave of medical breakthroughs that can transform lives in the future. The US spends nearly twice as much per person on new treatments compared to countries like Germany, Italy, and Spain. That means Americans are carrying more of the weight when it comes to funding the future of medicine, and Europeans are left waiting for years to access new medicines.
